Advisor Group Holdings, Inc. Pliant Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

$52.6 Billion
Q2 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 10,114 shares of PLRX stock, worth $15,069. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,114

Previous 114 8771.93%

Holding current value

$15,069

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Sep 04, 2025	BUY	$1.16 - $1.69 $11,600 - $16,900	10,000 Added 8771.93%	10,114 $11,000
Q2 2025 Aug 13, 2025	SELL	$1.16 - $1.69 $26,980 - $39,307	-23,259 Reduced 99.51%	114 $0
Q1 2025 May 12, 2025	BUY	$1.35 - $13.53 $15,684 - $157,191	11,618 Added 98.83%	23,373 $31,000
Q4 2024 Jun 06, 2025	SELL	$10.55 - $15.7 $122,569 - $182,402	-11,618 Reduced 49.71%	11,755 $154,000
Q4 2024 Feb 07, 2025	BUY	$10.55 - $15.7 $124,015 - $184,553	11,755 New	11,755 $154,000
Q2 2024 Aug 13, 2024	BUY	$10.58 - $15.61 $349 - $515	33 Added 10.09%	360 $3,000
Q1 2024 May 10, 2024	SELL	$14.14 - $19.59 $26,922 - $37,299	-1,904 Reduced 85.34%	327 $4,000
Q4 2023 Feb 12, 2024	SELL	$12.85 - $19.15 $50,256 - $74,895	-3,911 Reduced 63.68%	2,231 $40,000
Q3 2023 Nov 13, 2023	BUY	$14.58 - $20.15 $49,513 - $68,429	3,396 Added 123.67%	6,142 $106,000
Q2 2023 Aug 10, 2023	BUY	$18.12 - $30.56 $24,117 - $40,675	1,331 Added 94.06%	2,746 $49,000
Q1 2023 May 12, 2023	BUY	$18.73 - $36.26 $16,444 - $31,836	878 Added 163.5%	1,415 $37,000
Q4 2022 Feb 10, 2023	BUY	$17.0 - $25.43 $6,851 - $10,248	403 Added 300.75%	537 $10,000
Q3 2022 Nov 14, 2022	BUY	$7.67 - $24.23 $767 - $2,423	100 Added 294.12%	134 $3,000
Q1 2022 May 04, 2022	BUY	$7.01 - $14.1 $238 - $479	34 New	34 $0
Q3 2021 Nov 05, 2021	SELL	$16.48 - $28.98 $2,472 - $4,347	-150 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$28.05 - $37.69 $4,207 - $5,653	-150 Reduced 50.0%	150 $4,000
Q1 2021 May 13, 2021	SELL	$24.52 - $40.23 $15,938 - $26,149	-650 Reduced 68.42%	300 $12,000
Q4 2020 Feb 10, 2021	SELL	$19.89 - $32.99 $4,475 - $7,422	-225 Reduced 19.15%	950 $22,000
Q3 2020 Nov 12, 2020	SELL	$21.54 - $29.53 $13,462 - $18,456	-625 Reduced 34.72%	1,175 $27,000
Q2 2020 Aug 14, 2020	BUY	$21.3 - $35.26 $38,340 - $63,468	1,800 New	1,800 $58,000

Others Institutions Holding PLRX

# of Institutions

122

Shares Held

57.7M

Call Options Held

245K

Put Options Held

86.7K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $72.5M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Pliant Therapeutics, Inc. Transaction History